Prediabetes Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035)

Prediabetes Market Overview

Prediabetes represents an intermediate stage where blood glucose levels are higher than normal but not yet at diabetic levels, highlighting a critical window for prevention and intervention. Growing lifestyle changes, sedentary habits, and rising obesity rates are driving its global prevalence. The prediabetes market reflects increasing awareness, early diagnostic initiatives, and preventive treatment approaches, supported by healthcare advancements and government programs. With expanding therapeutic options and proactive patient engagement, the market is poised to grow at a CAGR of 6.40% during the forecast period of 2026-2035, offering opportunities for stakeholders across diagnostics, pharmaceuticals, and digital health solutions.

Prediabetes Market Growth Drivers

Rising Awareness of Prediabetes to Drive the Market Growth

The increasing awareness of prediabetes among adults is a significant growth driver in the market. According to the Cleveland Clinic, approximately 84 million adults in the United States are estimated to be prediabetic. The condition affects more than one in three adults under 65 and half of adults over 65. Despite its prevalence, over 80% of individuals with prediabetes remain undiagnosed due to the absence of noticeable symptoms. This growing recognition of the condition is prompting early screening and intervention efforts, thereby contributing to sustained market expansion.

Prediabetes Market Trends

Some of the trends in the market include dietary interventions and innovations in dual-action therapies.

Emphasis on Adopting Innovative Dietary Interventions

The use of targeted dietary interventions to support blood glucose management is a significant trend shaping the market. In January 2025, the BETA study conducted by the Quadram Institute demonstrated that regular consumption of broccoli soup could help normalize blood sugar levels in individuals with prediabetes. This 36-week double-blind trial also highlighted improvements in participants’ dietary habits and heightened awareness of nutrition. Such evidence-based dietary strategies are anticipated to enhance treatment approaches and contribute to sustained growth in the market.

Advancements in Dual-Action Therapies Driving Prediabetes Market Demand

The market is witnessing a trend toward therapies that combine weight management with diabetes prevention, reflecting the growing need for comprehensive interventions. In August 2024, the SURMOUNT-1 Phase 3 study highlighted that tirzepatide significantly reduced the risk of progression to type 2 diabetes by 94% in adults with pre-diabetes and obesity or overweight, while also achieving an average 22.9% weight reduction at the 15 mg dose. Such dual-action treatments demonstrate enhanced clinical outcomes, positioning the prediabetes market for sustained growth and increased adoption of innovative therapies.

Prediabetes Market Share

Adults to Lead the Market by Age Group

The market is segmented by age group into pediatrics, adults, and geriatrics, reflecting the diverse needs across different populations. Among these, the adult segment is expected to dominate, owing to the higher prevalence and greater awareness of prediabetes management within this group. According to the Centers for Disease Control and Prevention (CDC), more than 1 in 3 American adults has prediabetes, highlighting the critical demand for targeted interventions, monitoring tools, and preventive strategies focused on adults.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Prediabetes Market Analysis by Region

The market is divided into regions such as the United States, the United Kingdom, Germany, France, Italy, Spain, Japan, and India. Among these, the United States is expected to lead the market, driven by rising prediabetes prevalence, increased awareness, and adoption of advanced care strategies. In December 2024, the American Diabetes Association released the Standards of Care in Diabetes-2025, highlighting early diagnosis, lifestyle interventions, pharmacotherapy, and technology-based management for prediabetes and type 2 diabetes. These evidence-based guidelines are expected to reinforce the United States’ position as a key market leader.

Leading Players in the Prediabetes Market

Other key players in the market include Sanofi, Merck & Co., Inc., Glenmark Pharmaceuticals, GSK plc, Pfizer Inc., and Biocon Limited.

Prediabetes Market Segmentation

Key Questions Answered in the Prediabetes Market Report

• What was the prediabetes market value in 2025?
• What is the prediabetes market forecast outlook for 2026-2035?
• What are the major factors aiding the prediabetes market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major prediabetes market trends?
• Which drugs are expected to dominate the market segment?
• Which age group is projected to lead the market segment?
• Which route of administration is anticipated to drive the market segment?
• Which end user is likely to dominate the market segment?
• Which distribution channel is expected to dominate the market segment?
• Who are the key players involved in the prediabetes market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?